Member Info for Kevinl1977

WTF????
Chill dude
Enjoy some extremely positive news.

Hahahaha

16th December, 35 days after LPD.
First day of unblinding?

Doc
What are you on about?
They don’t need to fill the positions before releasing the news.
More like, we have the data, look at our RNS.
Now, tell me why you want this job?

All US based.
Is anyone going to tell me that they don’t know the quality of the results?
Positions of this magnitude would not be advertised as available if the Company confidence was anything short of very high!

Emergency ‘Use’ authorisation

I think he’s probably referring to the timeline between LPD and results readout, possibly from P2.
Approx 8/9 weeks.

FairPlay if you truly are making small profits, daily trading.
Very risky imo.

J CIT
Did you watch the Senator meeting the other day? The discussion was all around preparation for the next variants and stockpiling.
I have read somewhere that we have an agreement with a partner who is advising and supporting our potential use in the US, in the first instance!
Remember, that there are also 245 variants of the bat, as stated by SSH.

Just as well you haven’t got any shares then, eh.
No reason for you to post!

You have definitely justhadamare

Haha
Tag teams are out in force today!

Haha, joke 1st post.
DYOR

Thanks gggg, I wasn’t aware of that.

In fairness to CityT, whom I have criticised a few times due to incorrect predictions, he did say before the New Year that there was a new U.S investor snapping up a fair few shares.
If this is the one, we’ll done CT.

I’m sure Polygon and Ashfield know if they are working the numbers!!

Just sifting through Mercks approved Covid drug, which doesn’t appear to give us much to beat?
Huge orders have been put in place for the immediate and long term, mainly from US Government.
‘demonstrated as treatment with molnupiravir reduced hospitalizations and death: 14.1% (53/377) of patients in the placebo group were hospitalized or died, compared to 7.3% (28/385) of patients who received molnupiravir who were hospitalized; at the interim analysis, no patients who took molnupiravir died through Day 29, compared to eight patients who received placebo. The absolute risk reduction was 6.8 percentage points (95% CI: 2.4, 11.3; p=0.001, one-sided), which is approximately a 50% relative reduction in the risk of hospitalization or death through Day 29 for molnupiravir compared with placebo.’
Thoughts?

Excellent find gggg, someone’s confident.

“This is not the last variant, there will be another one. So governments all over the world, including ours, have to be ready and businesses have to be ready.”
The time has come for Government preparedness. Come on RM; now is the time to come to the party.
Positive data and the sky is the limit.

Ghia
Everyone is entitled to their opinion, of course. But reading the RNS below:
‘Synairgen will continue to work on the SPRINTER study with Parexel Biotech, a division of the leading global clinical research organisation, Parexel. Day 35 data will be reported in the first instance followed by the long COVID results which will be collected until Day 90.’
If Day 35 data isn’t read out until Feb 1st, that is 82 days since LPD.
Comparing the readout from our own P2 and also from the readout timelines of other companies in a similar position, which has been around 8/9 weeks.
I sincerely hope you’re wrong!